University of California

Massachusetts Institute of Technology

Arthur Prindle

Jeff Hasty

Sangeeta N Bhatia

Tal Danino

Lev S Tsimring

Muhammad Omar Din

Phillip Samayoa

Some embodiments described herein relate to cells which have been genetically engineered to release a polypeptide when a population of the cells reaches a desired density. In some embodiments, the released polypeptide may be a therapeutic polypeptide. In some embodiments, the therapeutic polypeptide kills tumor cells or which inhibits the growth of tumor cells.

Engineered bacteria for production and release of therapeutics

The present disclosure provides compositions comprising a food product, non-pathogenic microorganism, kits, methods of diagnosing a tumor in a subject, methods of quantifying the number of cancer cells in a cell sample, and methods of detecting a cancer cell, cancer tissue, or cell associated with a hyperproliferative disorder. In some embodiments, the method comprises a step of detecting the presence or absence of a modified substrate or portion thereof in urine of an animal without an instrument and solely by visual inspection of the urine.

Compositions and methods for cancer diagnosis

This invention provides a multiscale platform for coordinating behavior using synthetic biology. The platform reduces the impact of underlying noise, making outputs more coherent and reliable at the macroscopic level. In one aspect, the invention provides a frequency-modulated biosensor, comprising a microfluidic array comprising two or more separate colonies or populations of sensing cells to grow and communicate by gas exchange, wherein the colonies or populations of sensing cells output synchronized oscillating signals.

Multiscale platform for coordinating cellular activity using synthetic biology

Growing community of inventors

San Diego, CA, United States of America

Arthur Prindle